Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;19(1):150-9.
doi: 10.1007/s10120-014-0442-3. Epub 2014 Nov 25.

Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario

Affiliations

Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario

Matthew Dixon et al. Gastric Cancer. 2016 Jan.

Abstract

Background: Stage IV gastric cancer is lethal, and little population-based research on prognostic factors has been performed in low-incidence countries. Therefore, we investigated the consistency of the associations of patient, disease and healthcare system factors identified in previous population-based research to understand their generalizability to other low-incidence populations.

Methods: A population-based, retrospective cohort study of patients diagnosed with Stage IV gastric cancer in Ontario between 1 April 2005 and 31 March 2008 was performed. Kaplan-Meier methodology and the log-rank test were used for bivariate analysis. Multivariate Cox proportional hazard regression was performed. Hazard ratios (HRs) and 95% confidence intervals (CIs) are presented.

Results: On multivariate analysis, patient, disease and healthcare system factors were independent predictors of survival. Increasing age per 10 years (HR 1.07; 95% CI 1.02-1.10), a tumor located in the gastroesophageal junction (HR 1.09; 95% CI 0.94-1.27) or middle of the stomach (HR 1.14; 95% CI 0.97-1.35), presence of carcinomatosis (HR 1.61; 95% CI 1.42-1.83) and a larger burden of metastatic disease (2-3 sites of metastatic disease: HR 1.17; 95% CI 1.03-1.32; ≥ 4 sites: HR 1.69; 95% CI 1.30-2.20) were associated with worse prognosis. Female gender, receipt of surgery, chemotherapy and radiotherapy and treatment from a high-volume, gastric cancer specialist were all associated with significantly better prognosis. In addition, there was evidence of significant geographic variation in survival.

Conclusion: This study provides supporting evidence for patient, disease and healthcare system prognostic factors in metastatic gastric cancer. Future work investigating the role of emerging molecular and biologic information will need to take these established prognostic factors into consideration.

Keywords: Metastatic cancer; Prognostic factor.

PubMed Disclaimer

References

    1. J Gastrointest Oncol. 2011 Jun;2(2):77-84 - PubMed
    1. Gastric Cancer. 2012 Sep;15 Suppl 1:S125-37 - PubMed
    1. Stat Med. 1995 Aug 15;14(15):1707-23 - PubMed
    1. J Clin Oncol. 2012 Oct 1;30(28):3507-15 - PubMed
    1. J Gastrointest Surg. 2010 Nov;14(11):1660-8 - PubMed

Publication types

LinkOut - more resources